Supported by:
European
Commission
|
Title: European Science Foundation (ESF) Forward Look
Date and time: Monday 5 September 2005, 11.00 - 13.30
Nano Experts Running this Workshop
Chair: Professor Ruth Duncan
Co-chair: Julie Deacon (MNT Network)
Abstract
The European Science Foundation recently concluded a foresight study on the topic of nanotechnology applied to medicine (Scientific Forward Look on Nanomedicine). The goal of this Forward Look was to exchange views on the current status of Nanomedicine between scientific experts and policy makers, and to reflect upon future developments, opportunities and challenges facing this important field in Europe and worldwide. Over 100 international experts from academia, industry, private foundations and governmental agencies supporting scientific research have contributed to this activity.
The ESF Forward Look on Nanomedicine has led to a definition of the current status of the field and debates on strategic policy issues. This workshop launched the full ESF Policy Paper, summarising recommendations from the Forward Look activity. Implementation of recommendations from the ESF Scientific Forward Look on Nanomedicine would strengthen Europe’s leading-edge research and ensure further development in Nanomedicine, resulting in reduced healthcare costs and the rapid realisation of medical benefits for all European citizens. A summary of the outcome of this exercise can viewed in ESF Policy Briefing document No 23 (2005) at www.esf.org.
|
Workshop Programme and Timetable
|
| 10.30 |
Coffee |
|
| 11.00 |
Introduction to ESF and NanoMedicine Forward Look |
Prof. Clemens Sorg
Chair EMRC |
| 11.15 |
Overview of ESF Nanomedicine Forward Look and recommendations |
Prof. Ruth Duncan Cardiff University
Steering Committee Chair, ESF Forward Look on Nanomedicine |
| 11.30 |
Analytical Techniques and Diagnostic Tools |
Dr Julie Deacon, MNT Network |
| 11.50 |
Nanoimaging and Manipulation |
Dr Andreas Briel, Schering AG |
| 12.10 |
Nanomaterials and Nanodevices |
TBC |
| 12.30 |
Drug Delivery & Pharmaceutical Development |
Prof. Ruth Duncan, Cardiff University |
| 12.50 |
Clinical Applications and Toxicology |
Dr Ken Donaldson, University of Edinburgh |
| 13.10 |
Open Forum/Discussion |
All speakers |
| 13.30 |
Closing Comments and Networking lunch provided |
|
|
|
This event was been sponsored by the MNT Network.
Enquiries about the meeting should be addressed to Stephen Dennison (email: steve.dennison@pera.com).
|
|
|
|
|
|
|
|
| Endorsed By: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Partner: |
|
|
